Merieux Developpement: Boulder-Based Gene Editing Company Inscripta Secures $20 Million

Inscripta, a Boulder, Colorado-based gene editing company, has increased its previously announced Series C funding round with $20 million.The post Boulder-Based Gene Editing Company Inscripta Secures $20 Million appeared first on Pulse 2.0.